ATERO : A Randomised Study With Tranexamic Acid in Epistaxis of Rendu Osler Syndrome

Clinical trial NCT00355108 · COMPLETED

Trial details

NCT number: NCT00355108
Sponsor: Hospices Civils de Lyon
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Telangiectasia, Hereditary Hemorrhagic Osler-Rendu Disease

Start date: 2006-09-01
Primary completion: 2010-05-01
Enrollment: 170

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.